Cantitate/Preț
Produs

Advances in Molecular Pathology: Advances, cartea 6-1

Editat de Gregory J. Tsongalis
en Limba Engleză Hardback – 20 oct 2023
Advances in Molecular Pathology reviews the year’s most important findings and updates within the field in order to provide molecular pathologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Gregory Tsongalis, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Hardback (2) 90768 lei  5-7 săpt.
  Elsevier – 7 noi 2022 90768 lei  5-7 săpt.
  Elsevier – 20 oct 2023 90785 lei  5-7 săpt.

Din seria Advances

Preț: 90785 lei

Preț vechi: 129796 lei
-30% Nou

Puncte Express: 1362

Preț estimativ în valută:
16065 18838$ 14108£

Carte tipărită la comandă

Livrare economică 09-23 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780443130519
ISBN-10: 0443130515
Pagini: 240
Dimensiuni: 191 x 235 x 19 mm
Greutate: 0.64 kg
Editura: Elsevier
Seria Advances


Cuprins

The Landscape of Clinical Whole Genome Sequencing and the Emergence of Rapid Genetic Diagnosis in Critical Care
Blastic Plasmacytoid Dendritic Cell Neoplasm: Advances in Molecular Markers and Treatments
Molecular Classification of Diffuse Large B Cell Lymphoma: Impact on Prognosis and Treatment
B-Lymphoblastic Leukemia/Lymphoma: Newly Defined Entities and Subtypes by Molecular Methods
Molecular Diagnostics for Invasive Fungal Infections: Barriers to Widespread Adoption and Opportunities for Improvement
Recently Updated Sexually Transmitted Infection Screening Guidelines and Impact on Molecular Diagnostics
Quantitative Viral Load Monitoring: How far are We from Commutable Results?
The Current State of Pharmacoeconomics and Reimbursement for Pharmacogenomics
Long-read Sequencing for Germline Pharmacogenomic Testing
Practical Approaches to Pharmacogenomics in Patients Using Vitamins/Supplements and Medical Marijuana
Computer-Based Simulation of DNA Short[1]Read Next-Generation Sequencing: A Review of Software from a Clinical Perspective
Minimal Residual Disease Testing in Solid Tumors,
Mutational Signatures in Solid Tumors
Multi-Cancer Early Detection: Blood-Based Screening, Multiomics, Machine Learning, and New Clinical Pathways
Rapid Whole Genome Sequencing in Critically Ill Newborns
Molecular Diagnosis of Emerging Pathogens: Policy and Practical Considerations for Laboratorians